Curious to see your top suppliers emissions?
Book a demo for a pilot project
Bionano Genomics, Inc.
Medical Device ManufacturingUnited States
Last verified 10 months agobionano.com
Bionano Genomics, Inc., a leading player in the genomics industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2003, the company has made remarkable strides in genomic analysis, particularly through its innovative optical genome mapping technology. This unique approach allows researchers to visualise and analyse complex genomic structures with unprecedented clarity.
Bionano's flagship product, the Saphyr system, stands out for its ability to detect structural variations in DNA that traditional sequencing methods often miss. This capability positions Bionano as a vital resource for researchers in oncology, genetic disorders, and other fields requiring detailed genomic insights. With a strong market presence and a commitment to advancing genomic research, Bionano Genomics continues to drive innovation and enhance the understanding of genetic diseases.
13
DitchCarbon score
-16 vs industry average
Bionano Genomics, Inc.’s score of 13 is lower than 32% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Bionano Genomics, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Medical Device Manufacturing has below-average carbon intensity
Industry performance
0.308
20182025
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for Bionano Genomics, Inc. yet.
Bionano Genomics, Inc.'s reported carbon emissions
Bionano Genomics, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Bionano Genomics may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within the genomics sector, it may face increasing pressure to adopt sustainable practices and transparency in emissions reporting in line with broader industry trends.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Bionano Genomics, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Bionano Genomics, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Bionano Genomics, Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more